LBM22, a CLK2 inhibitor, exhibits an IC50 value of 3.9 nM. It possesses anti-proliferative properties by inhibiting the phosphorylation of SR proteins. Additionally, LBM22 downregulates the expression of Wnt-related proteins and anti-apoptotic proteins, making it applicable in the study of non-small cell lung cancer.
Molecular Weight:
512.51
Formula:
C28H22F2N6O2
Target:
CDK|||Apoptosis
T201198
* VAT and and shipping costs not included. Errors and price changes excepted
